• M344: Potent Histone Deacetylase Inhibitor for Cancer Resear

  2026-05-09

  M344 is a cell-permeable histone deacetylase inhibitor used to modulate gene expression and induce cell differentiation in cancer and HIV-1 latency models. It displays nanomolar IC50 potency and robustly inhibits breast cancer, medulloblastoma, and neuroblastoma cell proliferation. Evidence supports its role as an advanced tool for epigenetic research and workflow integration.

• E. coli Uracil-DNA Glycosylase (UDG): Technical Lab Guidance

  2026-05-08

  E. coli Uracil-DNA Glycosylase (UDG) is designed for the precise removal of uracil residues from DNA, supporting PCR contamination control and DNA repair workflows. It is not suitable for RNA, oligonucleotides shorter than six bases, or any diagnostic or clinical use. Researchers should apply it strictly within scientific research protocols where uracil excision from DNA is required.

• Primidone (Mysoline): Protocols and Innovations for TRPM3 &

  2026-05-08

  Primidone (Mysoline) offers unique selectivity as both a TRPM3 and RIPK1 inhibitor, enabling translational research in neurodevelopmental and neurodegenerative models. Explore optimized workflows, troubleshooting strategies, and data-driven dosing for reliable in vitro and in vivo outcomes.

• GSK126 EZH2 Inhibitor: Transforming Cancer Epigenetics Workf

  2026-05-07

  GSK126, a highly selective EZH2 inhibitor, empowers researchers to dissect PRC2-dependent gene silencing in cancer and stem cell models with unmatched precision. Its proven ability to enable self-renewal in naive pluripotent stem cells and enhance sensitivity to chemotherapeutics makes it indispensable for cutting-edge oncology and epigenetics research.

• GSK343: Advanced EZH2 Inhibitor Workflows for Epigenetic Res

  2026-05-07

  GSK343, a potent and selective EZH2 inhibitor from APExBIO, empowers researchers to precisely dissect PRC2-mediated gene repression and chromatin regulation in cancer and stem cell models. This article details optimized experimental workflows, advanced troubleshooting, and protocol parameters that leverage GSK343 for robust inhibition of histone H3K27 trimethylation, with actionable insights drawn from the latest discoveries in telomerase gene regulation.

• TRIM21 Drives ERK1/2 Activation and Drug Resistance in Pitui

  2026-05-06

  This study provides compelling evidence that TRIM21 promotes cell proliferation and dopamine agonist resistance in pituitary adenomas by modulating ERK1/2 ubiquitination and phosphorylation. Importantly, it identifies Quisinostat as a pharmacological agent capable of downregulating TRIM21, highlighting a potential therapeutic strategy for drug-resistant pituitary tumors.

• Gingerenone A Reverses Sunitinib Resistance via LDHA Inhibit

  2026-05-06

  This study identifies gingerenone A as a potent inhibitor of LDHA-mediated glycolysis in renal cell carcinoma (RCC), restoring sensitivity to sunitinib in resistant tumor models. By directly targeting metabolic reprogramming, gingerenone A offers a promising approach to overcoming tyrosine kinase inhibitor resistance in RCC.

• GSK126 EZH2 Inhibitor: Precision Targeting of Oncogenic Epig

  2026-05-05

  Explore the advanced applications of GSK126, a potent EZH2 inhibitor, in cancer epigenetics research. This article uniquely examines the mechanistic interplay between ETV5, EZH2, and tumor progression, offering actionable insights for oncology drug development.

• HDAC Inhibition and Drug Synergy in Pancreatic Cancer Models

  2026-05-05

  This study introduces an integrated cell and in vivo screening platform to identify chemotherapeutics for pancreatic ductal adenocarcinoma (PDA), highlighting the utility of Trichostatin A (TSA) as an epigenetic modulator that augments drug efficacy. The work demonstrates how TSA, in combination with gemcitabine and JQ1, suppresses tumor initiation and progression, offering a preclinical framework for rapid validation of therapeutic strategies.

• Perospirone (SM-9018 Freebase): Advanced Tools for Schizophr

  2026-05-04

  Perospirone (SM-9018 free base) offers a dual advantage for neuropsychiatric and cardiovascular studies, combining potent serotonergic/dopaminergic receptor modulation with selective Kv1.5 potassium channel inhibition. This guide details optimized experimental workflows, troubleshooting strategies, and protocol parameters to maximize reproducibility and specificity in schizophrenia and vascular research applications.

• AZ505 and SMYD2: Epigenetic Targeting Beyond Oncology Models

  2026-05-04

  Explore the multifaceted utility of AZ505, a potent SMYD2 inhibitor, in epigenetic regulation research. This article goes beyond cancer biology to analyze new evidence of SMYD2’s role in fibrosis and inflammation, offering actionable insights for advanced assay design.

• Co-targeting BRD4 and RAC1 Disrupts Oncogenic Epigenetic Net

  2026-05-03

  A recent study demonstrates that simultaneous inhibition of BET bromodomain BRD4 and RAC1 in diverse breast cancer subtypes suppresses tumor growth and stemness by dismantling the c-MYC–G9a–FTH1 axis and downregulating HDAC1. These findings highlight new epigenetic intervention strategies with relevance for cross-cancer research and provide mechanistic insights that could inform future therapeutic development.

• Apicidin (SKU A8176): Reliable HDAC Inhibition for Cell Assa

  2026-05-02

  This article examines how Apicidin (SKU A8176), a selective histone deacetylase inhibitor, addresses recurring laboratory challenges in cell viability, proliferation, and cytotoxicity assays. Drawing on peer-reviewed data and best practices, researchers will find practical guidance and comparative insights to improve workflow reliability and experimental reproducibility with Apicidin.

• NADH (Reduced-form Nicotinamide Adenine Dinucleotide): Mecha

  2026-05-01

  NADH, a pivotal coenzyme in cellular energy metabolism, drives redox reactions essential for ATP synthesis. This article details its mechanistic roles, benchmarked applications in mitochondrial electron transport chain research, and considerations for reproducible experimental workflows.

• EdU Imaging Kits (HF488): Precision DNA Synthesis Analysis i

  2026-05-01

  Explore how EdU Imaging Kits enable accurate cell proliferation assays by leveraging 5-ethynyl-2'-deoxyuridine click chemistry. This in-depth review dissects mechanistic advantages and connects assay performance to precision oncology breakthroughs.

15726 records 1/1049 page Next 12345 下5页 Last page